Houston, TX, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (SMMR). is pleased to announce that it has initiated contact with a US based BioScience research and testing facility in its efforts to further develop the Company's "Inducible Expression System for Biosynthetic Production of Testosterone in Men"
"We believe that we are on the right track in order to realize the full potential of this proprietary technology" says President Chad Reed who further states that "Additional details in regards to testing and development will be released as they become available"
About The Company:
The Company is in the business of creating, licensing and marketing nutraceutical products and is developing a proprietary human rejuvenation nutriceutical with the help of a small group of PhD molecular biologists. Symmetry believes that by isolating certain compounds, the effects will be inducement of apoptosis in senescent cells, stimulation of stem cell growth, and the suppression of herpes activity. The Company believes that by clearing tissues with short average telomere length and stimulating longer telomere cell growth, including differentiation from stem cell populations, while ameliorating the effects of HSV activity, they will produce an effect that is tantamount to cell rejuvenation. The Company is accomplishing these biological tasks using compounds that have been accepted as safe for human consumption and already approved by the FDA (Food and Drug Administration) for human use. Industry trends have shown that valid opportunities exist in the internet sales of nutraceuticals, This is based on the Company's belief that with effective marketing, astronomical opportunities will continue to exist in internet sales of both pharmaceutical and nutraceutical products, and that this multibillion dollar industry will continue to shift towards the majority of its sales being executed online. Additional information on the Company can be found at
Safe Harbor Statement:
This press release may contain forward-looking statements, within the meaning of Section 27 A of the 'Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. These forward-looking statements are only made as of the date of the press release and Symmetry Technologies Inc. does not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
CONTACT: Chad Reed firstname.lastname@example.org Source:Symmetry Technologies Inc.